ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
20.69
+1.01 (5.13%)
Nov 14, 2025, 4:00 PM EST - Market closed
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $854.11 million as of November 14, 2025. Its market cap has decreased by -19.19% in one year.
Market Cap
854.11M
Enterprise Value
553.90M
1-Year Change
-19.19%
Ranking
Category
Stock Price
$20.69
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $854.11M, an increase of 48.48%. That is a compound annual growth rate of 24.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 854.11M | -4.85% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |